메뉴 건너뛰기
American Journal of Medicine
Volumn 121, Issue 10, 2008, Pages e3-
Reduced High-density Lipoprotein Cholesterol in Patients Receiving Rosiglitazone and Fenofibrate
Author keywords

[No Author keywords available]
Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ATENOLOL; FENOFIBRATE; FLUINDOSTATIN; GLIPIZIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS VALSARTAN; METFORMIN; METOPROLOL; NICOTINIC ACID; PIOGLITAZONE; ROSIGLITAZONE; SIMVASTATIN; WARFARIN;
EID: 52949085742     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.06.019     Document Type: Letter
Times cited : (7)
References (6)
  • 1
    • 29244437857 scopus 로고    scopus 로고
    • The effect of dual PPAR alpha/gamma stimulation with combination of rosiglitazone and fenofibrate on metabolic parameters in type 2 diabetic patients
    • Seber S., Ucak S., Basat O., and Altuntas Y. The effect of dual PPAR alpha/gamma stimulation with combination of rosiglitazone and fenofibrate on metabolic parameters in type 2 diabetic patients. Diabetes Res Clin Pract. 71 (2006) 52-58
    • (2006) Diabetes Res Clin Pract. , vol.71 , pp. 52-58
    • Seber, S.1    Ucak, S.2    Basat, O.3    Altuntas, Y.4
  • 2
    • 33846210119 scopus 로고    scopus 로고
    • Paradoxical HDL-C reduction during rosiglitazone and fibrate treatment
    • Shetty C., Balasubramani M., Capps N., et al. Paradoxical HDL-C reduction during rosiglitazone and fibrate treatment. Diabet Med. 24 (2007) 94-97
    • (2007) Diabet Med. , vol.24 , pp. 94-97
    • Shetty, C.1    Balasubramani, M.2    Capps, N.3
  • 3
    • 19244369504 scopus 로고    scopus 로고
    • Paradoxical lowering of high-density lipoprotein cholesterol level in 2 patients receiving fenofibrate and a thiazolidinedione
    • Ebcioglu Z., Morgan J., Carey C., and Capuzzi D. Paradoxical lowering of high-density lipoprotein cholesterol level in 2 patients receiving fenofibrate and a thiazolidinedione. Ann Intern Med. 139 (2003) W80
    • (2003) Ann Intern Med. , vol.139
    • Ebcioglu, Z.1    Morgan, J.2    Carey, C.3    Capuzzi, D.4
  • 4
    • 34247849396 scopus 로고    scopus 로고
    • Severe acquired (secondary) high-density lipoprotein deficiency
    • Goldberg R.B., and Mendez A. Severe acquired (secondary) high-density lipoprotein deficiency. J Clin Lipidol. 1 (2007) 41-56
    • (2007) J Clin Lipidol. , vol.1 , pp. 41-56
    • Goldberg, R.B.1    Mendez, A.2
  • 5
    • 4444272941 scopus 로고    scopus 로고
    • Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol
    • Normen L., Frohlich J., Montaner J., et al. Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol. Diabetes Care 27 (2004) 2241-2242
    • (2004) Diabetes Care , vol.27 , pp. 2241-2242
    • Normen, L.1    Frohlich, J.2    Montaner, J.3
  • 6
    • 36248984242 scopus 로고    scopus 로고
    • High incidence of reduced plasma HDL cholesterol in diabetic patients treated with rosiglitazone and fibrate
    • Keidar S., Guttmann H., Stam T., et al. High incidence of reduced plasma HDL cholesterol in diabetic patients treated with rosiglitazone and fibrate. Pharmacoepidemiol Drug Saf. 16 (2007) 1192-1194
    • (2007) Pharmacoepidemiol Drug Saf. , vol.16 , pp. 1192-1194
    • Keidar, S.1    Guttmann, H.2    Stam, T.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.